Achillion Pharmaceuticals, Inc. Reports First Quarter 2014 Financial Results

Published: May 07, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW HAVEN, Conn., May 7, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three months ended March 31, 2014. For the first quarter of 2014, the Company reported a net loss of $16.1 million or $0.17 per share, compared with a net loss of $11.7 million or $0.14 per share for the first quarter of 2013. Cash, cash equivalents, marketable securities and interest receivable as of March 31, 2014 were $144.7 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news